AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2025
Apr 24, 2025
30786_dirs_2025-04-24_43ec8feb-920e-4764-b6b3-6e755f7c734e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIO.B)
CIK: 0000012208
Period of Report: 2025-04-22
Reporting Person: HINCKLEY GREGORY K (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-04-22 | Bio-Rad A Common Stock | M | 308 | — | Acquired | 308 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-04-22 | Restricted Stock Units | $0 | A | 407 | Acquired | Bio-Rad A Common Stock (407) | Direct | |
| 2025-04-22 | Restricted Stock Units | $0 | M | 308 | Disposed | Bio-Rad A Common Stock (308) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units will vest 100% on the earlier of the first anniversary of the grant date or the date of the company's next annual meeting of stockholders.
F4: On September 6, 2024, the reporting person was granted 308 restricted stock units, vesting at 100% on the earlier of the first anniversary of the grant date or the date of the Company's next annual stockholder meeting following the grant date.